Global Rheumatoid Arthritis Market DataPack (2016-2020)

  • ID: 3843371
  • Report
  • Region: Global
  • 48 pages
  • Koncept Analytics
1 of 3
The Industry DataPack provides a unique mix of market information, analysis and estimates based on quantitative and qualitative research.

The market figures and industry dynamics are given in order to determine the overall market potential and help the client in gaining a stronger foothold in the marketplace.

It presents a reliable assessment of the industry including key industry metrics, regional market analysis, market trends and growth drivers. It also explores the competitive landscape of the respective market with focus on major players.

The DataPack serves as a must read for anyone willing to invest in this market and trying to evaluate opportunities.
Note: Product cover images may vary from those shown
2 of 3
- Types of Arthritis
- Global Rheumatoid Arthritis Market by Value (2015-2020E)
- Global Rheumatoid Arthritis Market by Drug Class (2015/2020E)
- Global Rheumatoid Arthritis Market Share by Drug (2016E)
- Global Rheumatoid Arthritis Market Share by Biologics (2015)
- The US Rheumatoid Arthritis Market by Value (2015-2020E)
- The US Rheumatoid Arthritis Patient Prevalence (2015-2020E)
- The US Rheumatoid Arthritis Patient Penetration Rate (2015-2020E)
- The US Rheumatoid Arthritis Anti-TNF Population (2015-2020E)
- The US Rheumatoid Arthritis Biologics Population (2015-2020E)
- Global Female Population (2010-2015)
- Increasing Global Ageing Population of 60 Years or Older (2000-2030E)
- Global Healthcare Expenditure (2009-2015E)
- Increasing Cigarette Consumption (1910-2014)
- Increasing Obese Population (2010-2015E)
- Rheumatoid Arthritis Drug Prices (2013-2016E)
- Rheumatoid Arthritis Market Share by Company (2015/2020E)
- The US Rheumatoid Arthritis Brand (Company) Share (2016E)
- Abbvie Revenue Share by Pharmaceutical Products (2015)
- Abbvie Revenue Share by Region (2015)
- Abbvie Revenue and Net Income (2012-2015)
- Abbvie Research and Development Expenditure (2015)
- Johnson & Johnson Revenue by Segment (2015)
- Johnson & Johnson Revenue and Net Income (2012-2015)
- Amgen Revenue Share by Products (2015)
- Amgen Revenue and Net Income (2012-2015)
- Pfizer Inc. Revenue by Segment (2015)
- Pfizer Inc. Revenue and Net Income (2012-2015)
- Development Progress of Anti-IL-6 Drugs for RA (2015)
- Rheumatoid Arthritis Drug Approval and Developments (2015)
- Use of Complementary and Alternative Medicines (2015)
- Clinical Development of Biosimilars in Rheumatoid Arthritis (2015)
- Global Rheumatoid Arthritis Competition by Biologics (2015)
- New Products of Pfizer with FDA Approval (2015/2016)
- New Innovative Product Portfolio of Johnson & Johnson (2015)
- New Products of Pfizer with FDA Approval (2015/2016)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll